Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Light as a potential treatment for pandemic coronavirus infections: A perspective

These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This perspective paper cites several studies and argues that light-based phototherapy could help reduce coronavirus infections. The authors report that violet/blue light (400-470 nm) is antimicrobial against numerous bacteria and inactivates several viruses, and that red and near-infrared light reduced respiratory disorders in experimental animals. The abstract describes the work as a perspective and calls for further clinical exploration.

Who or what was studied
Experimental animals and patients with chronic obstructive lung disease or bronchial asthma, as described in cited studies
Wavelengths
400, 470 nm
Limits stated in the abstract
The abstract describes the paper as a perspective citing prior studies, and the authors call for further exploration of clinical value, so evidence for COVID-19 treatment is not established.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy-one of the most effective treatments used to reduce the impact of the 1918 "Spanish influenza" pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400-470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
400-470 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Phototherapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Other

Photobiomodulation: Shining Light on COVID-19

The most favorable range of optical radiation to operate in this system is between R-NIR region, in which cytochrome c oxidase and porphyrin present absorption peaks centered at 640 nm and HbO2 with absorption peak centered at 900 nm.

Study · June 9, 2020 · Fernandes AB et al.